Regulations
thumbnail
RegulationsOrchard $4.25m gene therapy approval a boon for AGC BioOrchard $4.25m gene therapy approval a boon for AGC Bio
CDMO AGC Bio will supply lentiviral vectors for Orchard Therapeutics’ metachromatic leukodystrophy (MLD) gene therapy, approved in the US this week.